Dont get me wrong...it could work out spectacularly. Chances are (if u look at the % of drugs that do clinical trials vs how many get FDA approval) it will fail and the cost will be in the multi-millions = debt and profit drain.
I'm just hoping if we get the patent approved they partner with a pharma company to share the cost of trials. I hate the ideas of this company going into debt on a risky drug.
Market Data 
Markets 
AI
